Delivery Order SPE2DR25D3004-SPE2DR26FXTJ1
- Not listed
- On January 9, 2026, the Defense Logistics Agency awarded a delivery order valued at $6,762.41 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units). This non-set-aside contract employs firm fixed-price pricing and is scheduled for completion by January 12, 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this order. The company operates as a subsidiary of Cencora, Inc., which...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on January 7, 2026, by the Defense Logistics Agency (DLA) for the supply of NURTEC ODT 75 MG tablets in quantities of eight units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $4,740.63 and is scheduled for completion by January 8, 2026. The award represents a task order under AmerisourceBergen's parent company...
- The Defense Logistics Agency awarded a delivery order valued at $3,871.92 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG Tablet 8S, a migraine treatment medication. The contract, awarded January 6, 2026, with an ultimate completion date of January 7, 2026, utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on December 31, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packaging) valued at $6,004.57. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The order is scheduled for completion by January 2, 2026, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $36,599.31 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (quantity: 8 units) on November 3, 2025, with completion targeted for November 4, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA. The pharmaceutical will be delivered to the contractor's primary location in...
- The Defense Logistics Agency's Medical Supply Chain issued a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of NURTEC ODT 75 mg tablets (8 count) with a ceiling value of $33,387.60. This is a firm fixed price, non-set-aside competitive award with an ultimate completion date of September 22, 2025. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $4,708.58 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8 count) on December 11, 2025, with an ultimate completion date of December 12, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $23,477.61 by the Defense Logistics Agency on October 24, 2025, for the supply of NURTEC ODT 75 mg tablets (8 count). This firm fixed-price contract, with an ultimate completion date of October 27, 2025, represents a competitively awarded, non-set-aside procurement supporting federal medical supply needs. The award is issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order on September 29, 2025, by the Defense Logistics Agency to supply 8 tablets of NURTEC ODT 75 mg, a prescription medication used to treat acute migraine headaches. This firm fixed-price delivery order has a ceiling value of $24,368.58 and is scheduled for completion by September 30, 2025. The award carries no set-aside designation, indicating it was competitively awarded through open competition. The order will be fulfilled from...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of NURTEC ODT 75 MG tablets (8-count packages). This competitive, non-set-aside contract is valued at $70,553.66 with firm fixed pricing and an ultimate completion date of September 29, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- SPE2DR25D3004Indefinite Delivery Contract
- SPE2DR25D3004-SPE2DR26FXTJ1Delivery Order
On January 9, 2026, the Defense Logistics Agency awarded a delivery order valued at $4,184.82 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG Tablet 8S, a migraine treatment medication. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The ultimate completion date is January 12, 2026, and performance will take place at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling supply of medications and medical commodities to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical federal medical procurement vendor. The company supplies a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to support military and veteran healthcare systems. The parent organization, Cencora, Inc., also maintains a significant Indefinite Delivery Contract with the Defense Logistics Agency valued at up to $999,999,999.00 through December 2031, further demonstrating the company's substantial role in supplying essential pharmaceuticals and medical commodities to federal healthcare institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 1/8/26 |